WallStreetZenWallStreetZen

NASDAQ: PRME
Prime Medicine Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRME past revenue growth

How has PRME's revenue growth performed historically?
Company
N/A
Industry
151.46%
Market
17.61%
PRME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

PRME earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$198.1M
Current Profit Margin
0%

PRME Return on Equity

Current Company
-93.7%
Current Industry
-63.5%
Current Market
188%
PRME's Return on Equity (-93.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PRME announces earnings.

PRME Return on Assets

Current Company
-76.9%
Current Industry
2.9%
PRME is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRME Return on Capital Employed

Current Company
-144.38%
Current Industry
19.5%
PRME's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRME vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRME$0.00-$180.97M-$198.13M-100.00%N/A
PROK$0.00-$25.61M-$35.47MN/AN/A
EXAI$25.74M-$192.47M-$187.13M+20.68%N/A
OLMA$0.00-$94.98M-$96.66MN/AN/A
PHAT$682.00k-$159.05M-$201.59MN/AN/A
View Top Biotech Stocks

PRME earnings dates

Next earnings date
May 9, 2024

Prime Medicine Earnings & Revenue FAQ

What were PRME's earnings last quarter?

On Invalid Date, Prime Medicine (NASDAQ: PRME) reported Q4 2023 earnings per share (EPS) of -$0.72, up 200% year over year. Total Prime Medicine earnings for the quarter were -$65.64 million. In the same quarter last year, Prime Medicine's earnings per share (EPS) was $0.72.

If you're new to stock investing, here's how to buy Prime Medicine stock.

What was PRME's earnings growth in the past year?

As of Q2 2024, Prime Medicine's earnings has grown year over year. Prime Medicine's earnings in the past year totalled -$198.13 million.

What is PRME's earnings date?

Prime Medicine's earnings date is Invalid Date. Add PRME to your watchlist to be reminded of PRME's next earnings announcement.

What was PRME's revenue last quarter?

On Invalid Date, Prime Medicine (NASDAQ: PRME) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Prime Medicine's revenue was $0.00.

What was PRME's revenue growth in the past year?

As of Q2 2024, Prime Medicine's revenue has grown null year over year. Prime Medicine's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.